Kamis, 12 Desember 2024

Google Alert - Business

Google
Business
Daily update December 13, 2024
NEWS
Stanford University News
To live in New York City is to be forever serenaded by an orchestra of honking cars. The Big Apple currently tops the list of the world's most congested urban areas. In 2024, the city's transit authority estimated people lost an average of 117 hours ...
Facebook Twitter Flag as irrelevant
Bureau of Transportation Statistics
U.S. airlines carried 77.5 million systemwide (domestic and international) scheduled service passengers in September 2024, according to the Bureau of Transportation Statistics (BTS). When adjusted for seasonality, September enplanements are down 0.4% from ...
Facebook Twitter Flag as irrelevant
www.abi.org.uk
The FCA and the Government are undertaking a joint review to examine the regulatory boundary between financial advice and financial guidance - known as the Advice Guidance Boundary Review. Their goal is to create a regulatory framework that ensures ...
Facebook Twitter Flag as irrelevant
California Energy Commission
For Immediate Release: December 11, 2024. WHAT YOU NEED TO KNOW: California continues to invest an unprecedented amount of funding to build a bigger, better, and more reliable network of electric charging and hydrogen refueling stations, ...
Facebook Twitter Flag as irrelevant
www.newrymournedown.org
From reusing items like plastic carrier bags and envelopes, to reducing food waste and choosing products with less packaging, we can all help to make the festive season more sustainable. This year, we are promoting ...
Facebook Twitter Flag as irrelevant
NATO HQ
December 12, 2024 – Ottawa, Ontario – National Defence / Canadian Armed Forces. The North Atlantic Treaty Organization's (NATO) Defence Innovation Accelerator for the North Atlantic (DIANA) has announced the successful innovators in 2024's competitive ...
Facebook Twitter Flag as irrelevant
The Institute of Cancer Research
One year of treatment with the targeted drug olaparib improves long-term survival in women with high-risk, early-stage breast cancer with mutations in BRCA1 or BRCA2 genes, new results from a major clinical trial show.
Facebook Twitter Flag as irrelevant
Reuters
Based on its review of postmarket clinical trial data, the U.S. Food and Drug Administration (FDA) identified cases of serious liver injury among patients being treated for primary biliary cholangitis (PBC) with Ocaliva (obeticholic acid) who did not have ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Tidak ada komentar:

Posting Komentar